Login
About

Menu

Login
About

VIDEOS+
Expanded Access Summit
Ax-S Thursdays
Faculty

Menu

VIDEOS+
Expanded Access Summit
Ax-S Thursdays
Faculty

Expanded Access 4.0 Registration Now Open! Join us for the largest annual conference on pre-market access to medicines. Now in virtual format. Register Now

Login
About

Menu

Login
About

VIDEOS+
Expanded Access Summit
Ax-S Thursdays
Faculty

Menu

VIDEOS+
Expanded Access Summit
Ax-S Thursdays
Faculty

EA3 Trailer Excerpt: Dr. Janet Woodcock

EA3 Trailer Excerpt Dr. Anthony Fauci
EA3 Dr. Anthony Fauci
EA3 Keynote by Dr. Janet Woodcock
EA3 Dr. Michael Kurilla (NCATS)
EA3 Dr. Hilary Marston (NIAID)
EA3 Dr. Robert Walker (BARDA)
EA3 Sessions 1 & 2 Fulfilling the Promise of Expanded Access
EA3 Session 3 Beyond the Simple Narratives
EA3 Session 4 Reimbursement for Exploratory Treatment Access
EA3 Session 6 The Integration of Research and Treatment
EA3 Session 7 Life Science and Healthcare Partnerships for Access
EA3 Session 8 Pre-Market Access for Population Needs and Contagion Outbreaks
Excerpt of Ax-S Thursdays Gleevec Interview
Ax-S Thursdays Case Review of Novartis Gleevec EAP
Excerpt of Ax-S Thursdays Ulixertinib Interview
Ax-S Thursdays Case Review of BVD Ulixertinib EAP
Excerpt of Ax-S Thursdays Dojolvi Interview
Ax-S Thursdays Case Review of Ultragenyx Dojolvi EAP
Expanded Access Explained in 4 Minutes
The Difference Between Cohort and Single-Patient Expanded Access
Why Expanded Access Matters to Me
The First Expanded Access Summit (2017)
EA1 (2017) Keynote, David Farber
EA1 (2017) Session 1, The First 30 Years of Expanded Access
EA1 (2017) Session 2, Operationalizing Expanded Access
EA1 (2017) Session 3, Economically Sustainable Access Programs
EA1 (2017) Session 4, Real World Evidence from EAPs
EA1 (2017) Session 5, Supporting Clinical Research with EAPs

EA3 Trailer Excerpt Dr. Anthony Fauci
EA3 Dr. Anthony Fauci
EA3 Keynote by Dr. Janet Woodcock
EA3 Dr. Michael Kurilla (NCATS)
EA3 Dr. Hilary Marston (NIAID)
EA3 Dr. Robert Walker (BARDA)
EA3 Sessions 1 & 2 Fulfilling the Promise of Expanded Access
EA3 Session 3 Beyond the Simple Narratives
EA3 Session 4 Reimbursement for Exploratory Treatment Access
EA3 Session 6 The Integration of Research and Treatment
EA3 Session 7 Life Science and Healthcare Partnerships for Access
EA3 Session 8 Pre-Market Access for Population Needs and Contagion Outbreaks
Excerpt of Ax-S Thursdays Gleevec Interview
Ax-S Thursdays Case Review of Novartis Gleevec EAP
Excerpt of Ax-S Thursdays Ulixertinib Interview
Ax-S Thursdays Case Review of BVD Ulixertinib EAP
Excerpt of Ax-S Thursdays Dojolvi Interview
Ax-S Thursdays Case Review of Ultragenyx Dojolvi EAP
Expanded Access Explained in 4 Minutes
The Difference Between Cohort and Single-Patient Expanded Access
Why Expanded Access Matters to Me
The First Expanded Access Summit (2017)
EA1 (2017) Keynote, David Farber
EA1 (2017) Session 1, The First 30 Years of Expanded Access
EA1 (2017) Session 2, Operationalizing Expanded Access
EA1 (2017) Session 3, Economically Sustainable Access Programs
EA1 (2017) Session 4, Real World Evidence from EAPs
EA1 (2017) Session 5, Supporting Clinical Research with EAPs

Ax-S Thursdays

AXSR Session 4 Highlights: Platform Trials
AXSR Session 1: Expanded Access and COVID19
AXSR Session 2: Real World Data from Hybrid Trials
AXSR Session 3: Decentralized Clinical Trials
AXSR Session 4: Platform Trials
AXSR Session 2: Tobias Polak, Real World Data from EAPs
AXSR Session 2: Dr. Amy Abernethy, the Learning Health System
AXSR Session 4: Dr. Merit Cudkowicz, Platform Trial in ALS

Expanded Access Summit 3.0

EA3 Trailer Excerpt Dr. Anthony Fauci
EA3 Dr. Anthony Fauci
EA3 Dr. Janet Woodcock
EA3 Dr. Michael Kurilla (NCATS)
EA3 Dr. Hilary Marston (NIAID)
EA3 Dr. Robert Walker (BARDA)
EA3 Sessions 1 & 2 Fulfilling the Promise of Expanded Access
EA3 Session 3 Beyond the Simple Narratives
EA3 Session 4 Reimbursement for Exploratory Treatment Access
EA3 Session 6 The Integration of Research and Treatment
EA3 Session 7 Life Science and Healthcare Partnerships for Access
EA3 Session 8 Pre-Market Access for Population Needs and Contagion Outbreaks

Case Reviews

Excerpt of Ax-S Thursdays Gleevec Interview
Ax-S Thursdays Case Review of Novartis Gleevec EAP
Excerpt of Ax-S Thursdays Ulixertinib Interview
Ax-S Thursdays Case Review of BVD Ulixertinib EAP
Excerpt of Ax-S Thursdays Dojolvi Interview
Ax-S Thursdays Case Review of Ultragenyx Dojolvi EAP

Explainers

Real World Evidence from Expanded Access Programs
AXSR Session 2: Tobias Polak, Real World Data from EAPs
AXSR Session 2: Dr. Amy Abernethy, the Learning Health System
Expanded Access Explained in 4 Minutes
The Difference Between Cohort and Single-Patient Expanded Access

EA Summit 1.0 (2017)

EA1 (2017) Keynote, David Farber
EA1 (2017) Session 1, The First 30 Years of Expanded Access
EA1 (2017) Session 2, Operationalizing Expanded Access
EA1 (2017) Session 3, Economically Sustainable Access Programs
EA1 (2017) Session 4, Real World Evidence from EAPs
EA1 (2017) Session 5, Supporting Clinical Research with EAPs

Promos and Vlogs

AXSR Session 4 Highlights: Platform Trials
AXSR Innovator Showcase: xCures
EA3 Trailer Excerpt: Dr. Hilary Marston
EA3 Trailer Excerpt: Dr. Michael Kurilla
EA3 Trailer Excerpt: Dr. Janet Woodcock
Excerpt of Ax-S Thursdays Gleevec Interview
Excerpt of Ax-S Thursdays Ulixertinib Interview
Excerpt of Ax-S Thursdays Dojolvi Interview
Why Expanded Access Matters to Me
The First Expanded Access Summit (2017)

Back to all videos

Get In Touch

hello@axspharma.com
San Francisco, CA | Washington DC

Pages

Ax-S Thursdays
Expanded Access Summit
Old Faculty

Menu

Ax-S Thursdays
Expanded Access Summit
Old Faculty

Resources

Video Resources
Papers and Publications
Regulatory References
Learning Modules
Custom Workshop
Blog

Menu

Video Resources
Papers and Publications
Regulatory References
Learning Modules
Custom Workshop
Blog

Conatct

Contact Us
About Us
Privacy Policy

Menu

Contact Us
About Us
Privacy Policy

© 2024 Ax-S Pharma – All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT REJECT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT